Description: Synthetic Biology enables the capability to manipulate and modify leaving cells and organisms to program them for specific purposes and has the potential to change the course of the healthcare sector. Synthetic Biology and its Consequences in Present Healthcare presents the latest findings and applications those in the healthcare sector need. Chapters cover a variety of synthetic biological tools in lifestyle diseases like obesity, heart disease, liver disease, type 2 diabetes and more. In addition, the vaccine development will cover DNA vaccines, synthetic and modified RNA-based vaccines, and personal vaccines for cancer, thus filling a gap in literature in the synthetic biology space. Written by international experts in the fields for those researching, practicing or studying in life sciences, biological sciences, including the synthetic biology domain.
Brief description: Dr. Bhupendra Gopalbhai Prajapati is Professor (Research Cadre) at Parul Institute of Pharmacy, Parul University, Gujarat, India, and serves as Adjunct Professor in the Department of Industrial Pharmacy at Silpakorn University, Thailand. His academic, research, and industry expertise focuses on lipid-based formulations, nano- and microparticulate drug delivery systems, and strategies to enhance drug bioavailability. Dr. Prajapati has received several academic and professional honors recognizing excellence in teaching and research. He has made substantial scholarly contributions through research and review publications, book chapters, and edited volumes in pharmaceutical sciences. Actively engaged in postgraduate and doctoral mentoring, he supports research training in advanced drug delivery and formulation science. Dr. Prajapati also serves in editorial and section-editor roles for international scientific publications, contributing to the advancement and quality of pharmaceutical research dissemination.